Metabolic syndrome, but not non-alcoholic fatty liver disease, increases 10-year mortality: A prospective, community-cohort study

被引:16
|
作者
Niriella, Madunil A. [1 ]
Kasturiratne, Anuradhani [1 ]
Beddage, Thulani U. [1 ]
Withanage, Shanthi A. [1 ]
Goonatilleke, Dilith C. [1 ]
Abeysinghe, Chathurika P. [1 ]
De Mel, Ruvini T. [1 ]
Balapitiya, Thilini L. [1 ]
De Silva, Shamila T. [1 ]
Dassanayake, Anuradha S. [1 ]
De Silva, Arjuna P. [1 ]
Pathmeswaran, Arunasalam [1 ]
Wickramasinghe, Ananda R. [1 ]
Kato, Nirihiro [2 ]
de Silva, Hithanadura J. [1 ]
机构
[1] Univ Kelaniya, Fac Med, Ragama, Sri Lanka
[2] Natl Ctr Global Hlth & Med, Toyama, Tokyo, Japan
关键词
fatty liver; metabolic syndrome; mortality; NAFLD; non-alcoholic fatty liver disease; LONG-TERM OUTCOMES; FIBROSIS STAGE; PREDICTS MORTALITY; ASSOCIATION; STEATOHEPATITIS; PREVALENCE; ADULTS; NAFLD; RISK;
D O I
10.1111/liv.14237
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Data on outcomes of non-alcoholic fatty liver disease (NAFLD) from South Asia are lacking. We compared mortality, among those with- and without-NAFLD, after 10-years follow-up among urban, adult Sri Lankans. Method Participants (aged 35-64 years), selected by age-stratified random sampling, were screened by structured-interview in 2007. Anthropometric measurements, liver ultrasonography and biochemical/serological tests were done. NAFLD was diagnosed on ultrasound criteria, safe-alcohol consumption (Asian-standards) and absence of hepatitis B/C. Subjects without NAFLD were those without any ultrasound criteria of fatty liver, safe-alcohol consumption and absence of hepatitis B/C. The cohort was re-evaluated to assess mortality in 2017. Participants or their households were contacted by telephone/post, and deaths confirmed by home-visits and death certificate review. Cox-regression was used to determine predictors of all-cause mortality (ACM) and cardiovascular mortality (CVM) in those with- and without-NAFLD. Results 2724 (91.2%) of 2985 original participants were contacted (851-with NAFLD and 1072-without NAFLD). Overall there were 169 (6.2%) deaths [41-deaths among NAFLD (17-cardiovascular; 9-cancer-related; 4-liver-specific; 11-other) and 79-deaths among no-NAFLD (28-cardiovascular; 17-cancer-related; 1-liver-specific; 33-other)]. Metabolic syndrome (MetS), low-education level, higher age and male-gender independently predicted ACM. MetS, increasing age and male-gender independently predicted CVM. NAFLD did not predict either ACM or CVM. In those with NAFLD, MetS and age >55-years were independently associated with ACM, while MetS and male-gender were associated with CVM. Conclusion In this community-based study, increasing age, male-gender and MetS, but not NAFLD, predicted 10-year ACM and CVM. Among those with NAFLD, only those metabolically abnormal were at a higher risk for mortality.
引用
收藏
页码:101 / 106
页数:6
相关论文
共 50 条
  • [1] Increased mortality in non-alcoholic fatty liver disease with chronic kidney disease is explained by metabolic comorbidities
    Onnerhag, Kristina
    Dreja, Karl
    Nilsson, Peter M.
    Lindgren, Stefan
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (05) : 542 - 550
  • [2] Metabolic syndrome and non-alcoholic fatty liver disease
    Almeda-Valdes, Paloma
    Cuevas-Ramos, Daniel
    Aguilar-Salinas, Carlos Alberto
    ANNALS OF HEPATOLOGY, 2009, 8 : S18 - S24
  • [3] Prediction of Metabolic Syndrome by Non-Alcoholic Fatty Liver Disease in Northern Urban Han Chinese Population: A Prospective Cohort Study
    Zhang, Tao
    Zhang, Yongyuan
    Zhang, Chengqi
    Tang, Fang
    Li, Hongkai
    Zhang, Qian
    Lin, Haiyan
    Wu, Shuo
    Liu, Yanxun
    Xue, Fuzhong
    PLOS ONE, 2014, 9 (05):
  • [4] Association between metabolic syndrome and the development of non-alcoholic fatty liver disease
    Wang, Yi
    Li, Yu Yuan
    Nie, Yu Qiang
    Zhou, Yong Jian
    Ca, Chuang Yu
    Xu, Lin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 6 (01) : 77 - 84
  • [5] Non-Alcoholic Fatty Liver Disease: Cause or Effect of Metabolic Syndrome
    Grander, Christoph
    Grabherr, Felix
    Moschen, Alexander R.
    Tilg, Herbert
    VISCERAL MEDICINE, 2016, 32 (05) : 329 - 334
  • [6] Metabolic syndrome, non-alcoholic fatty liver disease, and hepatocellular carcinoma
    Serradilla Martin, Mario
    Oliver Guillen, Jose Ramon
    Palomares Cano, Ana
    Ramia Angel, Jose Manuel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2020, 112 (02) : 133 - 138
  • [7] Metabolic profiles and fibrosis of non-alcoholic fatty liver disease in the elderly: A community-based study
    Chen, Tsung-Po
    Lai, Michelle
    Lin, Wen-Yuan
    Huang, Kuo-Chin
    Yang, Kuen-Cheh
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (09) : 1636 - 1643
  • [8] Is the Non-Alcoholic Fatty Liver Disease Part of Metabolic Syndrome?
    Genel, Sur
    Aurelia, Coroian
    Donca, Valer
    Emanuela, Floca
    JOURNAL OF DIABETES & METABOLISM, 2015, 6 (04)
  • [9] Incidence of liver-related morbidity and mortality in a population cohort of non-alcoholic fatty liver disease
    Mannisto, Ville T.
    Salomaa, Veikko
    Farkkila, Martti
    Jula, Antti
    Mannisto, Satu
    Erlund, Iris
    Sundvall, Jouko
    Lundqvist, Annamari
    Perola, Markus
    Aberg, Fredrik
    LIVER INTERNATIONAL, 2021, 41 (11) : 2590 - 2600
  • [10] Non-alcoholic fatty liver disease in the metabolic syndrome
    Palasciano, Giuseppe
    Moschetta, Antonio
    Palmieri, Vincenzo O.
    Grattagliano, Ignazio
    Iacobellis, Gianluca
    Portincasa, Piero
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (21) : 2193 - 2198